Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.45 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15019990 | 0.83 | RXFP1 (0.34) | PIK3CDRXFP1TGFBR1ALDH1A1TDP1 | |
| SCHEMBL21252699 | 0.83 | PIK3CD (0.34) | PIK3CDRXFP1TGFBR1ALDH1A1 | |
| SCHEMBL25685612 | 0.79 | RXFP1 (0.37) | RXFP1TGFBR1ALDH1A1TDP1KDM4E | |
| SCHEMBL9682306 | 0.78 | RXFP1 (0.34) | PIK3CDRXFP1TGFBR1ALDH1A1TDP1 | |
| SCHEMBL31616195 | 0.78 | TGFBR1 (0.34) | RXFP1TGFBR1 | |
| SCHEMBL6840899 | 0.78 | TGFBR1 (0.38) | PIK3CDRXFP1TGFBR1ALDH1A1TDP1 | |
| Hydrochloric Acid SCHEMBL8941472 | 0.77 | KDM4E (0.35) | PIK3CDRXFP1TGFBR1ALDH1A1KDM4E | |
| SCHEMBL13218356 | 0.76 | PIK3CD (0.48) | PIK3CDPOLB | |
| SCHEMBL21332619 | 0.76 | RXFP1 (0.35) | RXFP1TGFBR1ALDH1A1 | |
| SCHEMBL20633879 | 0.75 | PIK3CD (0.41) | PIK3CD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200388876-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH SILICON CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-12-10 | — | — | US | disclosed |
| EP-0857766-B1 | Process for producing aqueous ink for inkjet printing | KAO CORP (JP) | 2005-04-20 | — | — | EP | disclosed |
| US-5998501-A | DISSOLVING POLYMER AND HYDROPHOBIC DYE IN WATER INSOLUBLE SOLVENT; ADDING WATER AND NEUTRALIZING AGENT; EMULSIFICATION; DESOLVENTIZING | KAO CORPORATION (JP) | 1999-12-07 | — | — | US | disclosed |
| EP-0857766-A1 | Process for producing aqueous ink for inkjet printing | KAO CORPORATION (JP) | 1998-08-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200388876-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH SILICON CONTAINING ELECTROLYTE ADDITIVES | SELENOI, SIK1, SIK2 | PIK3CD 1567/4885RXFP1 4837/4885TGFBR1 4290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.